GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (FRA:BBZA) » Definitions » Valuation Rank

BB Biotech AG (FRA:BBZA) Valuation Rank


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

BB Biotech AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (FRA:BBZA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (FRA:BBZA) » Definitions » Valuation Rank
Comparable Companies
LSE:GNS LSE:ONT LSE:PRTC LSE:OXB LSE:BVXP LSE:HVO LSE:4BB LSE:AVCT LSE:FARN LSE:FUM OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
BIONz:UK BBZA:Germany BION:Switzerland
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
Website
https://www.bbbiotech.com
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.